Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab
-
M. Gutierrez
|
office@pagepress.org
- A. Becciolini
- C. Bertolazzi
- L. Di Geso
- M. Tardella
- A. Ariani
- E. Filippucci
- W. Grassi
Abstract
Over the last ten years, the treatment of seronegative spondyloarthropathies has changed dramatically with the introduction of the anti-tumor necrosis factor alpha (TNFα) agents. Nevertheless, there is a growing number of studies describing several adverse reactions in patients treated with biological agents. In the present report we describe the case of a 22-year-old male patient with ankylosing spondylitis who developed a “paradoxic” adverse reaction, while receiving infliximab.
Downloads
Download data is not yet available.
Statistics
- Abstract views: 914
- PDF: 498
How to Cite
Gutierrez, M., Becciolini, A., Bertolazzi, C., Di Geso, L., Tardella, M., Ariani, A., Filippucci, E., & Grassi, W. (1). Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab. Reumatismo, 62(3), 221-224. https://doi.org/10.4081/reumatismo.2010.221
Copyright (c) 1970 M. Gutierrez, A. Becciolini, C. Bertolazzi, L. Di Geso, M. Tardella, A. Ariani, E. Filippucci, W. Grassi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
